SST and obesity due to melanocortin 4 receptor deficiency: Synthetic analogues are structurally similar to natural SST and are currently used in the treatment of several pathological conditions including acromegaly and neuroendocrine tumours and have potential clinical applications in the management of inflammation and nociception, obesity, and diabetic complications [9,10,11,12,13].